Clinical Team

Kevin Riley, RN

Senior Clinical Education Specialist

clinical@paragonixtechnologies.com

Cardiology, vascular and thoracic clinical experience at MGH (Boston), Beth Israel Deaconess (Boston), California Pacific Medial Center (San Francisco), and UCSF Medical Center (San Francisco). Extensive experience in ex vivo heart and lung perfusion.

Ryan Mulcahy, RN CTP

Clinical Education Specialist

clinical@paragonixtechnologies.com

Over 13 years of tissue and organ donation as manager of organ placement and preservation, tissue recovery coordinator, and surgical recovery coordinator. Graduated with a BS in Nursing, a BS in Biology as well as a MSc in Biomedical Engineering.

Antonio Usan Mas

Senior Clinical Education Specialist (Europe)

antoniousan@paragonixtechnologies.com

30 years of medical device industry experience supporting pacemakers, ventricular assist devices, ECMO, ABO incompatible kidney transplant products, and ex vivo lung perfusion.

Management

Bill Edelman

Executive Chairman

Lisa M. Anderson, Ph.D.

Co-Founder, President and Chief Operating Officer

Carl Rickenbaugh

VP Business Development

Denise Weber

VP US Commercial Development

Adam Collette, Ph.D.

VP Commercial Operations

Richard Burtt

VP Investor Relations

Leonard A. R. Golding, MB, BS, FRACS, FRCS(C), FACC

Chief Medical Officer

Board of Directors

Bill Edelman

Nearly 35 years of medical device industry experience, including executive positions at St Jude Medical, Baxter, TYRX and PolyTouch Medical; Chairman of the Board for Vitathreads LLC, NewVert, Ltd., Highland Instruments, Inc., Medivalve, Ltd., and Cardioflow, Ltd.; CEO for ETView, Ltd., (TASE: ETVW)

Carl Rickenbaugh

34 years of medical technology industry experience including
executive M&A. Previously VP of New Business Development at CR
Bard. Commercial leadership positions at Abbott.

Lisa M. Anderson, Ph.D.

Previously VP at Seed One Ventures; various academic positions at University of Cambridge (UK), Broad Institute at Massachusetts Institute of Technology (Cambridge), Brigham & Women’s Hospital (Boston); Junior Faculty at Harvard Medical School.

Richard Burtt

35 years of medical device experience, including Andover Medical Industries, Medtronic, and Nomir Medical Technologies; Executive Chair at Advanced Aesthetic Technologies, Inc.; Managing Director of Value Added Strategies, LLC

Charles Hanor

IP litigation and patent trademark prosecution in Texas; adjunct professor at St. Mary’s University Law School; admitted to practice before the United States Supreme Court, Supreme Court of Texas, the United States Patent and Trademark Office and various United States district and circuit courts.

DeWitt Davenport

President and Trustee of Davenport Realty Trust, leading a diversified company based in Cape Cod, MA, with business interests located throughout New England; Trustee of Cape Cod Healthcare Inc., Eastern Bank and two family foundations; Director of Churchill Casualty Insurance and the Edward Bangs Kelley and Eliza Kelley Foundation, Inc. as well as Founder of the Seaside Le Mans – The Race for the Cape Cod Community

Scientific and Clinical Advisors

Muhammed Mohiuddin, MD

Professor of surgery and director of xenoheart transplantation in the department of surgery at the University of Maryland School of Medicine. Internationally renowned transplantation scientist specializing in cardiac xenotransplantation and related immunosuppressive therapies.

Steven Keller, MD, Ph.D.

Division of Pulmonary and Critical Care Medicine at the Brigham and Women’s Hospital, Boston. Faculty at the Harvard-MIT Biomedical Engineering Center.

Hari Mallidi, MD, FRCSC

Co-Director for Lung Transplant, ECMO and Lung Assist Devices within the Surgical Program in Heart and Lung Transplantation and Mechanical and Circulatory Support at the Brigham and Women’s Hospital, Boston.

Matthew Hartwig, MD

Thoracic Surgeon at the Duke Pulmonary Transplant Clinic at Duke University Medical Center; Associate Professor of Surgery at Duke.

Abbas Ardehali, MD, FACS

Professor of Surgery and Medicine in the Division of Cardiothoracic Surgery and Director of the Heart , Lung and Heart-Lung Transplant Programs at The David Geffen School of Medicine at UCLA. Chief of Cardiac Surgery at The Greater Los Angeles VA Healthcare System.

Steven S. L. Tsui, MA, MD, FRCS

Director of Transplant & Mechanical Circulatory Support program at Papworth Hospital, Cambridge, UK. Deputy Chair of the Cardiothoracic Advisory Group at NHS Blood & Transplant, UK, and the East of England Deanery Training Program Director in Cardiothoracic Surgery.

Joren Madsen, MD, DPhil

Professor of Surgery at Harvard Medical School and the W. Gerald & Patricia R. Austen Distinguished Scholar in Cardiac Surgery at Massachusetts General Hospital (MGH); Director of the Transplant Center and co-director of the Transplantation Biology Research Center at MGH

Andreas Zuckermann, MD

Staff Surgeon in the Department of Cardiac Surgery and Director of Transplantation at Medical University of Vienna, Austria; previously Director fo the International Society for Heart and Lung Transplantation.

Stefan G. Tullius, MD, Ph.D.

Chief of Transplant Surgery at Brigham and Women’s Hospital in Boston; Associate Professor of Surgery at Harvard Medical School and Principal Investigator at the Transplant Surgery Research Laboratory at BWH.